# VEOPOZ

NDC: 61755-014
Generic name: Pozelimab
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20230818

FDA application: BLA761339

## Active ingredients

- POZELIMAB: 200 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8d6f10e-9430-450a-a3dd-b538f9b2a308